| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $9.4M-38.7% | $15.3M-89.2% | $141.7M |
| Cost of revenue | $100.7M+161.7% | $38.5M+172.4% | $14.1M |
| Noncash compensation | $48.1M+53.1% | $31.4M+25.9% | $24.9M |
| Other research and development | $143.6M+72.7% | $83.1M+31.6% | $63.2M |
| Total research and development | $160.2M+69.9% | $94.3M+23.8% | $76.2M |
| Other selling, general and administrative | $184.0M+49.7% | $122.9M+25.7% | $97.8M |
| Total selling, general and administrative | $232.0M+50.4% | $154.3M+25.7% | $122.7M |
| Total costs and expenses | $493.0M+71.7% | $287.1M+34.8% | $213.0M |
| Operating income | $123.3M+194.1% | $41.9M+103.2% | $20.6M |
| Interest expense | $26.7M+11.2% | $24.0M+90.5% | $12.6M |
| Other income | -$10.8M-40.3% | -$7.7M-52.5% | -$5.0M |
| Total other expense | $15.9M-2.5% | $16.3M+115.8% | $7.6M |
| Net income before taxes | $107.4M+319.6% | $25.6M+95.9% | $13.1M |
| Income tax benefit (expense) | $339.8M+15468.1% | -$2.2M-466.9% | -$390K |
| Net income | $447.2M+1812.4% | $23.4M+84.5% | $12.7M |
| Basic (in dollars per share) | $3.10+1837.5% | $0.16+77.8% | $0.09 |
| Diluted (in dollars per share) | $2.77+1746.7% | $0.15+66.7% | $0.09 |
| Basic (in shares) | 144.32B-0.7% | 145.32B+2.4% | 141.96B |
| Diluted (in shares) | 161.41B+0.7% | 160.34B+8.0% | 148.51B |
| Product [Member] | |||
| License [Member] | |||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.